p38 MAPK might be at play as a pivotal intracellular signal transducer in endometriosis

In: Ensho Saisei · 2004 · vol. 24(6) , pp. 629–633 · doi:10.2492/jsir.24.629 · W2035973029
article OA: diamond CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-09

Inhibition of p38 MAPK with FR 167653 reduced endometriotic lesion growth and intraperitoneal inflammation in a mouse model.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text

This paper is a mini-review and accompanying experimental study assessing whether MAPK-driven inflammatory signaling is involved in endometriosis, focusing on p38MAPK as a potential intracellular signal transducer. In vitro, MAPK inhibitors tested suppressed IL-1β–induced IL-6 and IL-8 secretion and IL-1β–induced COX-2 expression in endometriotic cells, with the p38MAPK inhibitor FR 167653 showing the strongest inflammatory blockade. In an experimental mouse model, FR 167653 reduced the growth of endometriotic lesions and suppressed intraperitoneal inflammation, although the key limitation is that the evidence is presented from inhibitor-focused experiments rather than broader mechanistic validation. This paper is centrally about endometriosis — it argues for a p38MAPK-mediated inflammatory pathway and evaluates FR 167653’s effects in vitro and in mice.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Given the current theory of inflammatory changes being involved in the progression of endometriosis, MAPKs might be at play as pivotal intracellular signal transducers in endometriotic cells and thus have a pathophysiological role in the disease. In vitro study using endometriotic cell, all the MAPK inhibitors examined suppressed IL-1β-induced secretion of IL-6 and IL-8, and IL-1β-induced expression of COX-2 in endometriotic cells. Among MAPK inhibitors, p38MAPK inhibitor seemed to have the best potential to block inflammation. Then, the authors evaluated the effect of FR 167653, a p38MAPK inhibitor, on the development of endometriotic lesions and on the intraperitoneal inflammatory status using experimental model mice for endometriosis. FR 167653, a p38 MAPK inhibitor, caused a reduction in the growth of endometriotic lesions, coupled with the suppression of intraperitoneal inflammation. Thus, p38 MAPK inhibitors could have the therapeutic potential for endometriosis.
Full text 1,077 characters · extracted from oa-doi-fallback · click to expand
Mini Review 子宮内膜症におけるMAPKを介する炎症の解析と新たな治療戦略 2004 年 24 巻 6 号 p. 629-633 詳細 抄録 Given the current theory of inflammatory changes being involved in the progression of endometriosis, MAPKs might be at play as pivotal intracellular signal transducers in endometriotic cells and thus have a pathophysiological role in the disease. In vitro study using endometriotic cell, all the MAPK inhibitors examined suppressed IL-1β-induced secretion of IL-6 and IL-8, and IL-1β-induced expression of COX-2 in endometriotic cells. Among MAPK inhibitors, p38MAPK inhibitor seemed to have the best potential to block inflammation. Then, the authors evaluated the effect of FR 167653, a p38MAPK inhibitor, on the development of endometriotic lesions and on the intraperitoneal inflammatory status using experimental model mice for endometriosis. FR 167653, a p38 MAPK inhibitor, caused a reduction in the growth of endometriotic lesions, coupled with the suppression of intraperitoneal inflammation. Thus, p38 MAPK inhibitors could have the therapeutic potential for endometriosis. © 2004 日本炎症・再生医学会

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK